AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2015
Apr 16, 2015
35086_dirs_2015-04-16_cd5731a3-f6ce-4109-880f-507ec1c10c81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2015-04-14
Reporting Person: Luthringer Remy (Director, President, CEO & CSO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-14 | Stock Option (right to buy) | $5.19 | A | 399623 | Acquired | 2025-04-13 | Common Stock (399623) | Direct |
Footnotes
F1: The exercise price is the closing price of the Issuer's common stock on April 14, 2015.
F2: This option shall vest as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.
More from Minerva Neurosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
May 27
Share Issue/Capital Change
2026
May 27
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17